Class information for:
Level 1: ARIPIPRAZOLE//ASENAPINE//ILOPERIDONE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
8260 1201 43.7 77%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
278 18430 RISPERIDONE//CLOZAPINE//OLANZAPINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ARIPIPRAZOLE Author keyword 79 29% 19% 230
2 ASENAPINE Author keyword 65 63% 5% 65
3 ILOPERIDONE Author keyword 44 76% 3% 31
4 BLONANSERIN Author keyword 30 68% 2% 26
5 LURASIDONE Author keyword 26 47% 3% 41
6 CONDITIONED AVOIDANCE RESPONSE Author keyword 25 51% 3% 36
7 DEHYDROARIPIPRAZOLE Author keyword 24 82% 1% 14
8 PEROSPIRONE Author keyword 20 51% 2% 28
9 OPC 14597 Author keyword 18 89% 1% 8
10 OSU6162 Author keyword 17 79% 1% 11

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ARIPIPRAZOLE 79 29% 19% 230 Search ARIPIPRAZOLE Search ARIPIPRAZOLE
2 ASENAPINE 65 63% 5% 65 Search ASENAPINE Search ASENAPINE
3 ILOPERIDONE 44 76% 3% 31 Search ILOPERIDONE Search ILOPERIDONE
4 BLONANSERIN 30 68% 2% 26 Search BLONANSERIN Search BLONANSERIN
5 LURASIDONE 26 47% 3% 41 Search LURASIDONE Search LURASIDONE
6 CONDITIONED AVOIDANCE RESPONSE 25 51% 3% 36 Search CONDITIONED+AVOIDANCE+RESPONSE Search CONDITIONED+AVOIDANCE+RESPONSE
7 DEHYDROARIPIPRAZOLE 24 82% 1% 14 Search DEHYDROARIPIPRAZOLE Search DEHYDROARIPIPRAZOLE
8 PEROSPIRONE 20 51% 2% 28 Search PEROSPIRONE Search PEROSPIRONE
9 OPC 14597 18 89% 1% 8 Search OPC+14597 Search OPC+14597
10 OSU6162 17 79% 1% 11 Search OSU6162 Search OSU6162

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 OPC 14597 55 87% 2% 27
2 PSYCHOPHARMACOLOGICAL AGENT 45 90% 2% 19
3 PARTIAL AGONIST PROPERTIES 31 92% 1% 12
4 7 4 4 2 3 DICHLOROPHENYL 1 PIPERAZINYLBUTYLOXY 3 4 DIHYDRO 21H QUINOLIN OPC 14597 31 82% 1% 18
5 ANTIPSYCHOTIC DRUG 27 34% 5% 65
6 7 4 4 2 3 DICHLOROPHENYL 1 PIPERAZINYLBUTYLOXY 3 4 DIHYDRO 21H QUINOLIN 26 100% 1% 11
7 REVERSES MK 801 INDUCED IMPAIRMENT 26 64% 2% 25
8 AD 5423 24 91% 1% 10
9 MOUSE POLE TEST 18 89% 1% 8
10 ANTIPSYCHOTIC ILOPERIDONE 17 100% 1% 8

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic 2011 52 23 57%
A Review of the Pharmacology, Efficacy and Tolerability of Recently Approved and Upcoming Oral Antipsychotics: An Evidence-Based Medicine Approach 2013 15 78 64%
The importance of 5-HT1A receptor agonism in antipsychotic drug action: Rationale and perspectives 2010 55 81 62%
Cariprazine in Bipolar Disorder: Clinical Efficacy, Tolerability, and Place in Therapy 2013 11 4 75%
Asenapine review, part II: clinical efficacy, safety and tolerability 2014 4 55 67%
A Systematic Review of Aripiprazole-Dose, Plasma Concentration, Receptor Occupancy, and Response: Implications for Therapeutic Drug Monitoring 2010 30 30 77%
Comparative pharmacology of antipsychotics possessing combined dopamine D-2 and serotonin 5-HT1A receptor properties 2011 46 198 43%
Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability 2013 14 21 52%
Cariprazine in Schizophrenia: Clinical Efficacy, Tolerability, and Place in Therapy 2013 8 11 73%
Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT1A receptor activation 2014 8 106 30%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NEUROBIOL 2 5 25% 1.6% 19
2 QUESTS 4 56% 0.4% 5
3 SECT NEUROPSYCHOPHARMACOL 3 16% 1.5% 18
4 ALCOHOL DEPENDENCE 2 67% 0.2% 2
5 BIO OURCES DEV CONSERVAT PROGRAMME 2 67% 0.2% 2
6 CNRSFRE 3006 2 67% 0.2% 2
7 NEW DRUG DISCOVERY 2 2 27% 0.5% 6
8 PSICOFARMACOL EXPT 2 43% 0.2% 3
9 ETNOFAMACOL 1 100% 0.2% 2
10 PHARMACOLMINAMI KU 1 50% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000149358 CLOZAPINE//RISPERIDONE//OLANZAPINE
2 0.0000124655 VACUOUS CHEWING MOVEMENTS//TARDIVE DYSKINESIA//OROFACIAL DYSKINESIA
3 0.0000110425 DOPAMINE D 3 RECEPTOR//D 3 RECEPTOR//7 OH DPAT
4 0.0000094087 9 HYDROXYRISPERIDONE//NORCLOZAPINE//PALIPERIDONE
5 0.0000089215 5 HT6 RECEPTOR//5 HT7 RECEPTOR//SB 271046
6 0.0000083518 MPPF//F 18ALTANSERIN//F 18MPPF
7 0.0000083152 BUSPIRONE//5 HT1A LIGANDS//TANDOSPIRONE
8 0.0000078402 RECH PHARMACOCHIM SUBST NAT SYNTHET//3 SUBSTITUTED 1 4 BENZODIAZEPINE//AMDA
9 0.0000076966 PINDOLOL//VILAZODONE//NEUROBIOL PSYCHIAT UNIT
10 0.0000075859 C 11RACLOPRIDE//C 11FLB 457//F 18 FALLYPRIDE